These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38103940)

  • 21. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
    Lee AI; Wong CA; Healy L; Toledo P
    Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
    Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
    Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
    Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial.
    Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
    Trials; 2016 Mar; 17():155. PubMed ID: 27004531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation.
    Wing DA; Paul RH
    Am J Obstet Gynecol; 1998 Jul; 179(1):94-9. PubMed ID: 9704771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery.
    El Behery MM; El Sayed GA; El Hameed AA; Soliman BS; Abdelsalam WA; Bahaa A
    J Matern Fetal Neonatal Med; 2016; 29(8):1257-60. PubMed ID: 25946576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial.
    Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
    Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The optimal oxytocin infusion rate for preventing uterine atony during cesarean delivery in elderly parturients with prior history of cesarean delivery.
    Wang LY; Wang J; Dong JH; Ping ZP; Chen XZ; Wei CN
    Front Pharmacol; 2023; 14():1211693. PubMed ID: 37576820
    [No Abstract]   [Full Text] [Related]  

  • 29. Prophylactic Administration of Uterotonics to Prevent Postpartum Hemorrhage in Women Undergoing Cesarean Delivery for Arrest of Labor: A Randomized Controlled Trial.
    Balki M; Downey K; Walker A; Seaward G; Carvalho JCA
    Obstet Gynecol; 2021 Mar; 137(3):505-513. PubMed ID: 33543897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Guidelines on Perinatal Care - Oxytocin for induction and augmentation of labor[Formula: see text].
    ; Nunes I; Dupont C; Timonen S; ; Ayres de Campos D; Cole V; Schwarz C; Kwee A; Yli B; Vayssiere C; Roth GE; Gliozheni E; Savochkina Y; Ivanisevic M; Janku P; Timonen S; Daskalakis G; Beke A; Santo S; Druškovič M; Duvekot JJ; Farr A; Dreyfus M
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7166-7172. PubMed ID: 34470113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N; Mittal S; Kumar S
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey on the use of oxytocin for cesarean section.
    Marcus HE; Fabian A; Lier H; Dagtekin O; Böttiger BW; Teschendorf P; Petzke F; Valter M; Spöhr F
    Minerva Anestesiol; 2010 Nov; 76(11):890-5. PubMed ID: 20592672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discontinuing Oxytocin Infusion in the Active Phase of Labor: A Systematic Review and Meta-analysis.
    Saccone G; Ciardulli A; Baxter JK; Quiñones JN; Diven LC; Pinar B; Maruotti GM; Martinelli P; Berghella V
    Obstet Gynecol; 2017 Nov; 130(5):1090-1096. PubMed ID: 29016497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
    McDonagh F; Carvalho JCA; Abdulla S; Cordovani D; Downey K; Ye XY; Farine D; Morais M; Balki M
    Anaesthesia; 2022 Aug; 77(8):892-900. PubMed ID: 35343585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.
    Bischoff K; Nothacker M; Lehane C; Lang B; Meerpohl J; Schmucker C
    BMC Pregnancy Childbirth; 2017 Nov; 17(1):399. PubMed ID: 29187156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is high-dose misoprostol able to lower the incidence of cesarean section? A randomized controlled trial.
    de la Torre S; Gilson GJ; Flores S; Curet LB; Qualls CE; Rayburn WF
    J Matern Fetal Med; 2001 Apr; 10(2):85-90. PubMed ID: 11392598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.
    Kovacheva VP; Soens MA; Tsen LC
    Anesthesiology; 2015 Jul; 123(1):92-100. PubMed ID: 25909969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for complete uterine rupture.
    Al-Zirqi I; Daltveit AK; Forsén L; Stray-Pedersen B; Vangen S
    Am J Obstet Gynecol; 2017 Feb; 216(2):165.e1-165.e8. PubMed ID: 27780708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.